Angelina Gangestad, MD
Obstetrics & Gynecology · Cleveland, OHNPI 1952334476
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,435 of the $1,983 with a category attached, or 72.4%. 20 manufacturers reported payments, led by Bayer at 48.7% of the total. 2025 is the largest year on record at $950, 6.5 times the $147 reported in 2019.
Across 60 payments — averaging $33.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$966
- AbbVie$234
- Astellas Pharma US Inc$99
- Sumitomo Pharma America, Inc.$89
- Myovant Sciences Inc.$79
- Organon$77
- plus $439 from 14 others
Across 310 payments — averaging $2491.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$472K
- Medicines360$94K
- Sumitomo Pharma America, Inc.$63K
- Mitsubishi Tanabe Pharma Development America, Inc.$51K
- Genbiopro, Inc.$48K
- Abbott$44K
What the payments were for
- Travel & lodging$54728%
- Food & beverage$1,43572%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 8 | $966 |
| AbbVie(2 entities) | 15 | $234 |
| Astellas Pharma US Inc | 5 | $99 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| Myovant Sciences Inc. | 1 | $79 |
| Organon | 5 | $77 |
| Aspira Women's Health Inc | 1 | $69 |
| Exeltis, USA Inc. | 4 | $68 |
| Meditrina | 1 | $45 |
| Sage Therapeutics, LLC | 2 | $41 |
| Hologic Sales And Service, LLC | 2 | $40 |
| Johnson & Johnson | 1 | $37 |
| Merck | 3 | $35 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Mylan Pharmaceuticals Inc. | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Monaghan Medical Corporation | 2 | $15 |
| Duchesnay USA Incorporated | 1 | $13 |
| Coopersurgical, Inc. | 1 | $12 |
| Lupin Inc. | 1 | $11 |
How this compares
$1,983 in reported general payments places this provider in the 75th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremproEstrogen,con/M-Progest Acet | 11 | $4,458 |
| Estradiol | 21 | $1,709 |
| Raloxifene Hcl | 15 | $624 |
| Trospium Chloride ErTrospium Chloride | 12 | $456 |
| Medroxyprogesterone Acetate | 11 | $429 |
| Fluconazole | 18 | $83 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cleveland
- Oluwatosin GojeCleveland$81K
- Jeffrey MangelCleveland$61K
- Julian PeskinCleveland$33K
- Shirley BennettCleveland$25K
- Robert PollardCleveland$16K
- Linda BradleyCleveland$15K
- Alexander KotlyarCleveland$13K
- Kathryn CoyneCleveland$12K
- Samir AhujaMentor$430K
- Burton BrodskySylvania$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.